EJP-RD Networking Support Scheme

The Call for the Research – European Joint Programme on Rare Diseases (EJP RD) Networking Support Scheme (NSS) is now open! The scheme will provide financial support to applicants for fostering organization of workshops or conferences for new research networks or existing/expanding research networks to strengthen collaborations and to enable…

Continue reading

EJP RD Joint Transnational Call (JTC) 2020

A preliminary announcement on the European Joint Programme on Rare Diseases (EJP RD) Joint Transnational Call (JTC) 2020 has just been released! The topic for this call is “Pre-clinical research to develop effective therapies for rare diseases” Research proposals must cover at least one of the following areas: Development of novel therapies…

Continue reading

Orphacodes Project

The objective of this action is to support Member states in improving the gathering of information on rare diseases by the implementation of Orphacodes (rare diseases specific codification system). For more information click here Submission deadline: 26 April 2018 at 17:00 PM (CET)

Continue reading

ERA-CVD Joint Transnational Call 2018

The European Research Area Network on Cardiovascular Diseases (ERA-CVD) has announced the Joint Transnational Call 2018 (JTC 2018) entitled “Transnational Cardiovascular Research Projects driven by Early Career Scientists” that opened on January 11th, 2018. This call is open to all early career scientists, which is defined as a scientist that…

Continue reading

10th E-Rare-3 Call for Proposals 2018

The launch of the 10th E-Rare-3 Call for Proposals 2018 “Transnational research projects on hypothesis-driven use of multi-omic integrated approaches for discovery of disease causes and/or functional validation in the context of rare diseases” occurred on December 7, 2018. This call is aimed at scientists from different countries (see link…

Continue reading

E-Rare 3 Call for Proposals 2018

Publication of the call of December 7th! JTC 2018: “Transnational research projects on hypothesis-driven use of multi-omic integrated approaches for discovery of disease causes and/or functional validation in the context of rare diseases” More information here

Continue reading